Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders
Authors
Keywords
-
Journal
Genes
Volume 13, Issue 1, Pages 109
Publisher
MDPI AG
Online
2022-01-06
DOI
10.3390/genes13010109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
- (2021) Suzan M Hammond et al. EMBO Molecular Medicine
- Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
- (2021) John W Day et al. LANCET NEUROLOGY
- Gene therapy for ALS: A review
- (2021) Defne A. Amado et al. MOLECULAR THERAPY
- Failure of genetic therapies for Huntington’s devastates community
- (2021) Diana Kwon NATURE
- Double setback for ASO trials in Huntington disease
- (2021) Katie Kingwell NATURE REVIEWS DRUG DISCOVERY
- Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood–brain barrier and knock down genes in the rodent CNS
- (2021) Tetsuya Nagata et al. NATURE BIOTECHNOLOGY
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions
- (2021) Xiaolin Zhu et al. Frontiers in Molecular Neuroscience
- Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS
- (2021) Tomoki Hirunagi et al. Molecular Therapy-Nucleic Acids
- Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity
- (2021) Wooi F. Lim et al. Science Advances
- Fourth Boy Dies in Clinical Trial of Astellas' AT132
- (2021) Alex Philippidis HUMAN GENE THERAPY
- Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
- (2021) Eugenio Mercuri et al. LANCET NEUROLOGY
- Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue
- (2021) Gretchen Thomsen et al. NATURE MEDICINE
- Clinical development on the frontier: gene therapy for duchenne muscular dystrophy
- (2020) Damon R. Asher et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo
- (2020) Masayuki Nakamori et al. NATURE GENETICS
- SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS
- (2020) Christian Mueller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy
- (2020) Kenji Rowel Q. Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
- (2020) Jerry R. Mendell et al. JAMA Neurology
- Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)
- (2020) Atsushi Hashizume et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development Therapeutics
- (2020) Juergen Scharner et al. MOLECULAR THERAPY
- Bioconjugated oligonucleotides: recent developments and therapeutic applications
- (2019) sebastien benizri et al. BIOCONJUGATE CHEMISTRY
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in molecular therapies for neurological disease: triplet repeat disorders
- (2019) Pedro Gonzalez-Alegre HUMAN MOLECULAR GENETICS
- Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease
- (2019) Bryan Zeitler et al. NATURE MEDICINE
- A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
- (2019) Julia F. Alterman et al. NATURE BIOTECHNOLOGY
- Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders
- (2019) Ana C Silva et al. BRAIN
- Molecular Mechanisms and Therapeutics for SBMA/Kennedy’s Disease
- (2019) Frederick J. Arnold et al. Neurotherapeutics
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polyglutamine Repeats in Neurodegenerative Diseases
- (2018) Andrew P. Lieberman et al. Annual Review of Pathology-Mechanisms of Disease
- Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis
- (2017) Zhang-Yu Zou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study
- (2017) Alan H. Beggs et al. MUSCLE & NERVE
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
- (2017) Hichem Tasfaout et al. Nature Communications
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
- (2016) Tsukasa Sugo et al. JOURNAL OF CONTROLLED RELEASE
- Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice
- (2016) Cy A Stein MOLECULAR THERAPY
- MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy
- (2016) Naemeh Pourshafie et al. MOLECULAR THERAPY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy
- (2015) Kentaro Sahashi et al. HUMAN MOLECULAR GENETICS
- Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia
- (2015) Megan S. Keiser et al. HUMAN MOLECULAR GENETICS
- Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy
- (2014) Constanza J. Cortes et al. NEURON
- Oligonucleotide-based strategies to combat polyglutamine diseases
- (2014) A. Fiszer et al. NUCLEIC ACIDS RESEARCH
- Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy
- (2014) Andrew P. Lieberman et al. Cell Reports
- Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2
- (2012) Yu Miyazaki et al. NATURE MEDICINE
- Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism
- (2010) Jiaxin Hu et al. CHEMISTRY & BIOLOGY
- Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
- (2010) Kevin D Foust et al. NATURE BIOTECHNOLOGY
- Rational Design of Antisense Oligomers to Induce Dystrophin Exon Skipping
- (2009) Chalermchai Mitrpant et al. MOLECULAR THERAPY
- Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy
- (2009) Isabella Palazzolo et al. NEURON
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started